Abstract: A biodegradable based polymers for the production of biodegradable medical applications is provided. The biobased material has a copolymer constituted by dextran modified with glycidyl methacrylate and poly (#-caprolactone) modified with 2-isocyanatoethylmethacrylate, which are combined in different formulations and used to produce membranes, 3-D scaffolds and hollow tubes that can be used as biomedical devices for diverse applications, such as drug delivery systems, tissue engineering scaffolds, repair and regeneration of peripheral nerves, among others.

Abstract: A fixture in the form of a shelf that can be mounted to a support bar secured to the inner face of a refrigerator door. The shelf is telescopic and has at least two parts, a base and a platform, both being slidable upon each other and slidable along the support bar. The base and the platform have mounting means on the support bar and route-limited fitting and sliding means therebetween. The fixture allows for an increase or reduction in space of the telescoping shelf for better arranged storage of beverage cans or the like, in order to ensure versatility and safety to the arrangement of cited products.

Abstract: A fixture in the form of a shelf that can be mounted to a support bar secured to the inner face of a refrigerator door. The shelf is telescopic and has at least two parts, a base and a platform, both being slidable upon each other and slidable along the support bar. The base and the platform have mounting means on the support bar and route-limited fitting and sliding means therebetween. The fixture allows for an increase or reduction in space of the telescoping shelf for better arranged storage of beverage cans or the like, in order to ensure versatility and safety to the arrangement of cited products.

Abstract: The present utility model refers to a low density EPS crushing and compacting machine, providing its recycling with the aim to conserve the environment in educational and marketing campaigns for public locations. The machine basically comprises a feed dome, crusher and compactor and is characteristically provided for use by a user under training and/or without any familiarity with the operation and, therefore, equipped with more efficient safety devices and sized for easy transport and installable at exhibitions, events, trainings, educational action settings, etc.

Abstract: Disclosed are methods for treating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Alzheimer's Disease Parkinson's Disease, Myasthenia Gravis, Multifocal Motor Neuropathy, Primary Lateral Sclerosis, Spinal Muscular Atrophy, Kennedy's Disease, and Spinocerebellar Ataxia.

Abstract: Methods and therapeutic compositions are disclosed for treating neurodegenerative disorders and, in particular Amyotrophic Lateral Sclerosis, using sphingosine1-phosphate receptor modulators, such as fingolimod or a pharmaceutically acceptable salt, hydrate, or solvate thereof.

Abstract: Methods and therapeutic agents are disclosed for treating neurodegenerative disorders by depletion of CD8 positive T cells by using antibodies, FAb fragments of antibodies or similar agents that sequester, neutralize or deplete the CD8+ cytotoxic T cells.

Abstract: Disclosed are methods for treating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Parkinson's Disease, Myasthenia Gravis, Multifocal Motor Neuropathy, Primary Lateral Sclerosis, Spinal Muscular Atrophy, Kennedy's Disease, and Spinocerebellar Ataxia, by administration of a compound that blocks the interaction of CD40 and CD40L.

Abstract: Methods and therapeutic agents are disclosed for treating neurodegenerative disorders by depletion of CD8 positive T cells by using antibodies, FAb fragments of antibodies or similar agents that sequester, neutralize or deplete the CD8+ cytotoxic T cells.

Abstract: Disclosed are methods for treating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Parkinson's Disease, Myasthenia Gravis, Multifocal Motor Neuropathy, Primary Lateral Sclerosis, Spinal Muscular Atrophy, Kennedy's Disease, and Spinocerebellar Ataxia, by administration of a compound that blocks the interaction of CD40 and CD40L.